According to WHO data, since the identification of the cause of acquired immunodeficiency syndrome (AIDS) in 1984, the human immunodeficiency virus (HIV) has infected more than 80 million people and caused 40Read More…
Using nucleoside modified mRNAs in lipid nanoparticles (mRNA-LNP) as a vaccine for COVID-19 may successfully predict a new era of vaccine development. For HIV-1, polyvalent enveloped trimer protein nanoparticles may be usedRead More…
Nearly 40 years after the discovery of HIV, it has killed 36.3 million people, but so far there is still no effective vaccine available. In a new study, however, researchers from theRead More…
Recently, the University of Oxford in the United Kingdom started a first phase clinical trial of a new HIV vaccine candidate in the United Kingdom. The trial, called HIV-CORE 0052, aims toRead More…
One of the reasons why it is so difficult to make effective vaccines against certain viruses, including influenza and HIV, is that these viruses mutate very quickly. This allows them to escapeRead More…
In a recent study published in Science Advances, scientists from the Scripps Research Institute overcame technical hurdles to develop a new HIV vaccine candidate that stimulates the body to produce a powerfulRead More…